<SEC-DOCUMENT>0001437749-24-037238.txt : 20241211
<SEC-HEADER>0001437749-24-037238.hdr.sgml : 20241211
<ACCEPTANCE-DATETIME>20241211161233
ACCESSION NUMBER:		0001437749-24-037238
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20241211
DATE AS OF CHANGE:		20241211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		241541659

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>nby20241206_defa14a.htm
<DESCRIPTION>FORM DEFA14A
<TEXT>
<html><head>
	<title>nby20241206_defa14a.htm</title>

	<!-- Generated by ThunderDome Portal - 12/6/2024 1:25:52 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SCHEDULE 14A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proxy Statement Pursuant to Section 14(a) of</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>the Securities Exchange Act of 1934 </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Amendment No. )</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant&nbsp;&#9746;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant&nbsp;&#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Definitive Proxy Statement</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Definitive Additional Materials</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting Material Pursuant to &#167;&nbsp;240.14a-12</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 100%; text-align: center; font-size: 12pt; border-bottom: 1px solid black;"><b>NOVABAY PHARMACEUTICALS, INC.</b></td>
		</tr>
		<tr>
			<td style="text-align: center;">(Name of Registrant as Specified in Its Charter)</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 100%; border-bottom: 1px solid black;">&nbsp;</td>
		</tr>
		<tr>
			<td style="text-align: center;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">No fee required</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Fee paid previously with preliminary materials</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div style="text-align: center;"><img alt="image01.jpg" src="image01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><font style="color:#ff0000;"><b>YOUR VOTE IS STILL NEEDED</b></font></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><font style="color:#ff0000;"><b>THE RECONVENED MEETING IS FAST APPROACHING</b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Dear Fellow NovaBay Stockholder:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Special Meeting of Stockholders of NovaBay Pharmaceuticals Inc. (NYSE: NBY) that was adjourned on November 22, 2024, is scheduled to be reconvened on December 18, 2024 and your vote is still needed<b>.</b>&nbsp;<b> Even if you have recently sold your shares, you are still entitled to vote!</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Proposal One &nbsp;is a proposal to approve the sale of Avenova, representing substantially all of the assets of&nbsp; NovaBay (the &#8220;Asset Sale&#8221;), pursuant to the Asset Purchase Agreement, dated September 19, 2024, by and between NovaBay and PRN Physician Recommended Nutriceuticals, LLC, and Proposal Two is a proposal to approve the liquidation and dissolution of NovaBay, pursuant to the Plan of Complete Liquidation and Dissolution of NovaBay (the &#8220;Plan of Dissolution&#8221;) which, if approved, would authorize NovaBay to liquidate and dissolve in accordance with the Plan of Dissolution, and pursuant to the discretion of the Board of Directors to proceed with the dissolution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ISS, the leading proxy advisory firm, recommends voting in favor of Proposals One and Two.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><font style="color:#ff0000;">We urgently ask you to vote <b><u>TODAY</u>!</b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Every stockholder&#8217;s vote is important regardless of how many shares you may own.&nbsp; Please submit your proxy as soon as possible.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The fastest and easiest way to vote is by telephone or over the Internet. Instructions on how to vote your shares over the telephone or Internet are enclosed with this letter. If you would like to speak to me personally about the business or the proposals, please reach out to me via email so we can schedule a time to connect. My email address is listed below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Thank you for your investment in NovaBay and for taking the time to vote your shares. Getting this vote passed is important to NovaBay and to the other stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Sincerely,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Very truly yours,</p>

<div><img alt="image02.jpg" src="image02.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall, Esq.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Chief Executive Officer</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>jhall@novabay.com</u></p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">NOVABAY PHARMACEUTICALS, INC.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">2000 Powell St, Suite 1150, Emeryville, CA 94608 &#8226; Phone: (510) 899-8870 &#8226; Fax: (510) 255-0371</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !7 2T# 2(  A$! Q$!_\0
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M@J,J;G3D..85X55"K$^DJ*S]9UFRT#39+^_E*0H0.!EF)Z #N:\YN_C*=_\
MH>B_(#UGGP2/H!Q^=>?2P]2KK!'IUL52HZ39ZM17D4?QFNMX\S182G?;<'/_
M *#7;>&?&^G^*(9EM8WBO8DW-:R$9(]5/0C/&:JIA:M-7DM":6,HU'RQEJ=/
M17FK_&&QC=HWT6\5T)5E+ID$<$5WVF:G;ZII-MJ4!Q!/$)!N_A&.0?I43HU*
M:O)6-*>(I5&U!WL7**\UE^,>F)*ZII=VZ*Q <.H##/6N\TC4#JND6M^;=[?[
M0@D$4A!8 ],X]1S^-%2C4IJ\U8*>(IU6U!W+U%%%9&P4M)2T )1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/4444 %%%% !2T44 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W '8# 2(  A$! Q$!_\0
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##__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
